{
    "nctId": "NCT01055678",
    "briefTitle": "To Evaluate the Characteristics of a Breast Cancer",
    "officialTitle": "Pilot Study to Characterize the HRHV Axis in the Microenvironment of Breast Cancers",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "To evaluate tumor characteristics",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed Stage 0 - III invasive carcinoma of the breast\n* Tumor size greater than 1-cm by radiological (mammogram/ultrasound or MRI) evaluation\n* KPS status \u2265 70\n* Bilirubin \u2264 1.5x normal\n* Creatinine \u2264 1.8\n* WBC \\> 3000/mm\\^3 and platelets \\> 100,000/mm\\^3\n\nExclusion Criteria:\n\n* Pregnant or breast-feeding women\n* Neoadjuvant chemo or hormonal therapy for existent breast malignancy\n* Allergy to IV contrast dye\n* History of grade III or IV peripheral neuropathy as defined by the NCI CTC\n* Previous history of any malignancy treated with radiotherapy and/or chemohormonal therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}